Novel consent process for research in dying patients unable to give consent
Objectives To develop a process of advance consent to enable research to be undertaken in patients in the terminal phase. Design Feasibility study of an advance consent process to support a randomised controlled trial of two antimuscarinic drugs (hyoscine hydrobromide and glycopyrronium bromide) in...
-д хадгалсан:
| -д хэвлэсэн: | BMJ |
|---|---|
| Үндсэн зохиолчид: | , |
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMJ Publishing Group
2003
|
| Нөхцлүүд: | |
| Онлайн хандалт: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166125/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12881261/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.327.7408.198 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|